Received May 26, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | Z016260 | OT |
nausea, diarrhea, headache, extreme fatigue and lethargy, loss of appetite, runny nose, body aches, and 5 to 6 large welts near the injection site that are painful, swollen and itchy; nausea, diarrhea, headache, extreme fatigue and lethargy, loss of appetite, runny nose, body aches, and 5 to 6 large welts near the injection site that are painful, swollen and itchy; nausea, diarrhea, headache, extreme fatigue and lethargy, loss of appetite, runny nose, body aches, and 5 to 6 large welts near the injection site that are painful, swollen and itchy; nausea, diarrhea, headache, extreme fatigue and lethargy, loss of appetite, runny nose, body aches, and 5 to 6 large welts near the injection site that are painful, swollen and itchy; 5 to 6 large welts near the injection site that are painful, swollen and itchy. the welts are 2 to 3 fingers wide and long; nausea, diarrhea, headache, extreme fatigue and lethargy, loss of appetite, runny nose, body aches, and 5 to 6 large welts near the injection site that are painful, swollen and itchy; nausea, diarrhea, headache, extreme fatigue and lethargy, loss of appetite, runny nose, body aches, and 5 to 6 large welts near the injection site that are painful, swollen and itchy; nausea, diarrhea, headache, extreme fatigue and lethargy, loss of appetite, runny nose, body aches, and 5 to 6 large welts near the injection site that are painful, swollen and itchy; This Spontaneous report was received from a consumer, reporting on herself, 79 -year-old Female patient. The patient's concurrent condition included Penicillin, azitrhomycin, sulfa drugs and prednisone allergy. The patient's historical drugs included Penicillin, Azithromycin (reported as arythromycin), and Prednisone. Her concomitant medications were not reported. On 18-May-2026, the patient was vaccinated with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE), prefilled syringe, at a dose of 0.50 mL, Batch/Lot Number: Z016260, expiration date not reported but established as 14-Aug-2027, administered intramuscularly as prophylaxis (site of administration was unknown). On an unknown day in May 2026, the patient experienced nausea, diarrhea, headache, extreme fatigue and lethargy, loss of appetite, runny nose, body aches, and 5 to 6 large welts near the injection site that are painful, swollen and itchy (vaccination site urticaria). It was also reported that the welts are 2 to 3 fingers wide and long. The patient did not seek medical attention nor treatment was given for the events. At the time of the report, the outcome of the events was not resolved. The causal association between the events and Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) was not provided.
Drug allergy